For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Sun Pharma Q1 Profit Surges 31% YoY Even As Margins Contract

|

Sun Pharmaceuticals reported a 31.2% y-o-y jump in net profit for the quarter ended June at Rs. 1,338 crore even as its margins took a hit. The revenue of the largest Indian drug manufacturing company came in at Rs. 8,374 crore, an increase of 15.9% over the last year.

Sun Pharma Q1 Profit Surges 31% YoY Even As Margins Contract
 

Notably, the country's pharma sector too is reeling under slowdown and registered slowest growth in 5 years time in the quarter ended June. Also, pharmaceutical companies such as Sun Pharma which primarily sell their generic drugs in the US face intense competition and pricing pressure, forcing them to cut down on prices and hence settle for lower profitability.

EBITDA of the company climbed 13.7% to Rs. 1696 crore while its operating margin narrowed down to 23%, with a decline of 50 basis point of 0.5%.

Shares of Sun Pharma closed 3.71% higher at Rs. 437.55 despite a 1.66% fall in the benchmark Sensex.

GoodReturns.in

Read more about: sun pharma earnings margin
Company Search
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more